Biostage, Inc.
BSTG · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $58,417 | $53,151 | $62,425 | $23,143 |
| - Cash | $2,486 | $0 | $1,241 | $1,242 |
| + Debt | $294 | $0 | $147 | $169 |
| Enterprise Value | $56,225 | $53,151 | $61,331 | $22,070 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$270 | -$24 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$8,156 | -$9,093 | -$5,923 | -$8,894 |
| % Margin | – | – | – | – |
| Net Income | -$7,732 | -$9,022 | -$6,073 | -$7,978 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.52 | -0.67 | -1.09 | -0.74 |
| % Growth | 22.4% | 38.5% | -47.3% | – |
| Operating Cash Flow | -$4,852 | -$6,939 | -$5,106 | -$2,628 |
| Capital Expenditures | $0 | -$11 | -$5 | $0 |
| Free Cash Flow | -$4,852 | -$6,950 | -$5,111 | -$2,628 |